Breast Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with localised breast cancer and have finished their main treatment (surgery, and/or chemotherapy, and/or radiotherapy) within the last 6 months
- People who scored 5 or higher on a distress measurement scale called the Distress Thermometer
- People aged 18 or older
- People who have signed a consent form agreeing to take part in the trial
- People who have had a previous cancer diagnosis, including a previous breast cancer
- People who have had previous cancer treatment, including chemotherapy for a prior cancer
- People who are currently taking part in another clinical drug trial
- People who are currently on, or are planned to start, certain ongoing treatments lasting more than 3 months during the study period — such as anti-HER2/neu therapy, immune checkpoint inhibitors, anti-hormonal therapy, CDK4/6 inhibitors, or other additional cancer treatments
- People who are using other complementary therapies, including mistletoe therapy
Who may not be able to join:
- People who have language difficulties or cognitive difficulties (including reduced consciousness) that would make taking part in the study not possible
- People with serious physical or psychiatric health conditions that would prevent participation in the study
- People who are not in a position to give their own informed consent
- People who are pregnant
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Viola Heinzelmann-Schwarz, Prof.MD, University Hospital of Basel
Phone: +41 61 265 85885
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Distress at 8 weeks of intervention
Can't join this trial?
Data last synced from ClinicalTrials.gov: 23 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.